Clinical Trial: Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure - Performance Evaluation Study
Study Status: Completed
Recruit Status: RECRUITING
Condition: This Study is Conducted Under Inclusion/ Exclusion Criteria
Study Type: INTERVENTIONAL
Official Title: Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure - Performance Evaluation Study
Brief Summary:
Minimally Invasive Micro Sclerostomy (MIMS®) device is intended for the reduction of elevated Intraocular Pressure (IOP).MIMS® is a powered surgical device, designed to create a drainage channel of 100 microns diameter at the sclera-corneal junction and extending from the anterior chamber to the interface between the sclera and the conjunctiva (subconjunctival space), at the inferonasal quadrant of the eye (i.e., inferonasal sclerostomy).The drainage channel is created by a sterile surgical device made of…
Read more